Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 818 results for "iias"

IiAS, Ingovern support Wipro offer
Business Standard

IiAS, Ingovern support Wipro offer

shareholders of Wipro Enterprises (WEL), the unlisted consumer care arm of the IT major Wipro, to accept the exit option provided by the company. In separate reports, Bengaluru-based Ingovern Research and Mumbai-based Institutional Investor Advisory Services ... Business Standard, 1 month ago

28 images for iias

Saudi Gazette, 2 days ago
Institute of Internal Auditors, 1 week ago
European Pharmaceutical Review, 3 weeks ago
Star of Mysore, 2 weeks ago
KXXV-TV, 2 weeks ago
LEDs Magazine, 2 weeks ago
Queensland Times, 3 weeks ago
Howard County Times, 3 weeks ago
Bio Spectrum Asia, 3 weeks ago
VOA News, 3 weeks ago

Ipsen picks up option to buy Canbex once PhIIa data rolls in

Ipsen (EPA:IPN) has handed over €6 million ($6.8 million) for the option to buy British biotech Canbex Therapeutics. The French biopharma will decide whether to pull the trigger after getting a look at Phase IIa data on Canbex's lead candidate, a ...
 FierceBiotech1 day ago Ipsen Gains Option to Buy Canbex Therapeutics for $6.8M+  Genetic Engineering News2 days ago Ipsen secures option to buy Canbex Therapeutics [EMBIN (Emerging Markets Business Information News]  Pharmacy Choice5 minutes ago


FINANCIAL RESULTS FOR 2014 FY2014 in line with Company expectations Solid cash position of €5.6 million; financial structure significantly strengthened by equity line of up to €20 million Inititation of two clinical trials of IFN ...
 EuroInvestor1 hour ago REG-NEOVACS : FINANCIAL RESULTS FOR 2014  Reuters1 hour ago DGAP-News: Neovacs S.A.: FINANCIAL RESULTS FOR 2014  TeleTrader.com1 hour ago Neovacs S.A.: FINANCIAL RESULTS FOR 2014  Ariva.de1 hour ago

Ipsen Inks Option Deal to Acquire Canbex Therapeutics

Ipsen and Canbex Therapeutics reported that Canbex has granted Ipsen an option giving Ipsen the exclusive right to purchase 100 percent of Canbex shares upon completion of the Phase IIa study of Canbex's lead candidate for the treatment of ...
 Individual.com1 day ago Ipsen to acquire Canbex Therapeutics  PharmaBiz1 day ago Ipsen signe une option dachat pour lacquisition de Canbex..  ADVFN Australia3 days ago Ipsen Enters into Option Agreement to Acquire Canbex Therapeutics  Town Hall3 days ago

Joint USAF/NOAA Solar Geophysical Activity Report and Forecast 26 February 2015

Joint USAF/NOAA Solar Geophysical Activity Report and Forecast SDF Number 57 Issued at 2200Z on 26 Feb 2015 IA. Analysis of Solar Active Regions and Activity from 25/2100Z to 26/2100Z: Solar activity has been at very low levels for the past 24 ...
 SpaceRef3 hours ago
ABC Online

Why the Campaign to Reform the Racial Discrimination Act Failed

The Abbott government's plan to amend Part IIA of the Racial Discrimination Act 1975 (RDA), covering race hate provisions, ignited fierce public debate and finally came to nothing. Three enduring factors explain why the government's proposed ...
 ABC Online5 hours ago

Woodford forms Imperial-heavy board, Prexton exits Serono's shadow, Chiesi bags stem cell nod

Welcome to the latest edition of our weekly EuroBiotech Report . Neil Woodford revealed the board of his new fund this week and hinted at his strategy in the process. With three-quarters of the board having biotech credentials and the same ...
 FierceBiotech5 hours ago

New HIV Maturation Inhibitor Shines in Pilot Study (CME/CE)

Action Points Note that this study was published as an abstract and presented at a conference. These data and conclusions should be considered to be preliminary until published in a peer-reviewed journal. Note that this proof-of-concept study ...
 MedPage Today8 hours ago Bristol-Myers Squibb Release: Study Of Next-Generation Investigational HIV-1 Maturation Inhibitor Shows Positive Results In Preventing Viral Replication Via Different Mechanism Of Action Than Current Therapies  BioSpace13 hours ago Bristol-Myers Squibb's clinical candidate represents a new class of drugs potentially able to address unmet medical needs in HIV-1 patients  PipelineReview16 hours ago BMS Maturation Inhibitor Is Potent Against HIV in Early Trial  AIDSmeds16 hours ago

TetraLogic Reports 2014 Financial Results and Provides Clinical Programs Update

MALVERN, Pa., Feb. 26, 2015 (GLOBE NEWSWIRE) -- TetraLogic Pharmaceuticals Corporation (Nasdaq:TLOG), a clinical-stage biopharmaceutical company focused on discovering and developing novel small molecule therapeutics in oncology and infectious ...
 4 Traders11 hours ago

Malaviya Chair at IIT-BHU brings cheer

Varanasi: Railway Minister Suresh Prabhu's announcement of 'Malaviya Chair' for Railway Technology at the Indian Institute of Technology, Banaras Hindu University (IIT-BHU) was received with cheers by the BHU family and also local citizens. It also ...
 Times of India11 hours ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - iias
Get updated on latest news & your favorite topics right in your inbox!
More     Less